Synthesis, characterization, and anticancer evaluation of N -(5,7-dimethyl-1,8-naphthyridin-2-yl) benzamide scaffolds
The development of novel anticancer agents remains a key focus in medicinal chemistry. We hypothesized that benzamide substitution of the 1,8-naphthyridine scaffold would enhance anticancer activity. In this study, we report a rapid, efficient, and environmentally benign green synthetic approach for the construction of a new series of N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide derivatives (5a-h). The synthesized compounds were characterized using standard spectroscopic techniques. All compounds were evaluated for their in vitro anticancer activity against three human cancer cell lines: MCF-7, A549, and Colo-205. The results revealed that the tested compounds exhibited significant anticancer activity. Among them, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-2-nitrobenzamide (5e) and 2-chloro-N-(5,7-dimethyl-1,8-naphthyridin-2-yl)benzamide (5c) showed the most potent activity, with IC50 values of 6.06 ± 0.14 μM (MCF-7), 8.36 ± 0.36 μM (A549), and 12.27 ± 0.73 μM (Colo-205) for compound 5e, and 8.06 ± 0.29 μM (MCF-7), 10.72 ± 0.49 μM (A549), and 15.39 ± 0.43 μM (Colo-205) for compound 5c, compared with the standard drug.
Authors
- Kavati Shireesha
- Kumara Swamy Jella (ORCID: https://orcid.org/0009-0009-6240-811X)
- Shaganti Venkatesh
Institutions
- Chaitanya (IN)
Publication Details
- Journal
- Synthetic Communications
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1080/00397911.2026.2764714
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00